| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.03 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |